Xcout IntelAcelyrin, Inc
Acelyrin, Inc. is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases. Its lead program, izokibep, is an interleukin-17A inhibitor…
The full profile of Acelyrin, Inc
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Acelyrin, Inc →Already a subscriber? Sign in
Xcout Intel tracks Acelyrin, Inc continuously — this profile deepens as new filings, funding, people and hiring data arrive.